ChatGPT is Poised to Disrupt Medical Affairs
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
With a multibillion dollar investment from Microsoft and already 4 authorship credits on PubMed, ChatGPT is poised to disrupt Medical Affairs.
MAPS speaks with Tim Mikhelashvili, CEO and Co-Founder of Amedea Pharma, and the winners of his Medical Affairs Olympics Competition, the CEOs of Discreedly and Inphronesis.
In today’s episode, we’re talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment.
The webinar discusses how to engage with Digital Opinion Leaders (DOLs) and how they can be a valuable source of insights, with a strong focus on the compliance aspects. Increasing numbers of pharma stakeholders are active in social media and thereby present an open and accessible opportunity for the gathering of insights. When Pharma listens to these DOLs it needs to be done in a compliant way. The same applies to the engagement with DOLs. The webinar addresses these topics and the important role Medical has to play when listening and engaging with DOLs.
In this episode, our expert speakers are talking about virtual scientific congresses and what has changed since the pandemic.
In this webinar, experts will:
1.    Discuss the current environmental landscape for conversational AI/Chatbots
2.    Provide practical learning through a case study presentation on how to implement conversational AI/Chatbots (KPIs, use cases, metrics, learnings)
3.    Identify and debate legal and regulatory considerations when implementing conversational AI/Chatbots
In the 3rd and final episode of this series, we’ll be meeting with Georgios Tramountanis, a member of the MAPS Digital Focus Area Working Group to examine where we see potential opportunities for Medical Affairs as it relates to Automation and review some predictions on the future of Automation in Medical Affairs.
In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industry.
In this webinar, you’ll learn:
This white paper is inspired by an inquiry to the Medical Affairs Professional Society (MAPS) Digital Focus Area Working Group (FAWG) requesting guidance on best practices to establish a digital framework within Medical Affairs at a small pharmaceutical company. While this paper seeks to provide this specific guidance, the digital framework described herein is not only applicable to small organizations but can be seen as a basic digital framework for Medical Affairs teams in biopharmaceutical and MedTech organizations of any size.
Digital tools power the ability of Medical Affairs teams to generate, analyze and disseminate data to external stakeholders across the product lifecycle, while at the same time bringing essential learnings from these stakeholders back to the organization in the form of insights. That said, no single digital structure or set of digital tools will be appropriate for all organizations. Thus, rather than considering the recommendations of this paper a one-size-fits-all system, it is important to evaluate how digital transformation may empower and support a company’s core beliefs and key messages.
Importantly, no matter the specifics of implementation, we recommend a vision-first approach to digital – only once an organization’s vision has been established is it appropriate or even possible to successfully define the digital pillars needed to implement and execute this vision.
Once a company’s vision is clear, Medical Affairs teams may consider the core components of developing a Medical Affairs digital strategy and plan shown in Figure 1, each of which will be discussed in turn.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.